A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)
Trial details
- Registry ID
- NCT04439071
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
Also recorded as Emvododstat
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)NCT04439071 | PTC Therapeutics | Phase 2, Phase 3 | Terminated | 2022-07-20Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |